These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis Presenting as Idiopathic Orbital Inflammatory Syndrome. Wagley S; Wang Y; McClelland CM; Chen JJ; Lee MS J Neuroophthalmol; 2021 Mar; 41(1):e46-e47. PubMed ID: 32108670 [No Abstract] [Full Text] [Related]
7. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders. Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767 [TBL] [Abstract][Full Text] [Related]
8. Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis? Lee AR; El-Dairi MA JAMA Ophthalmol; 2018 Oct; 136(10):e182928. PubMed ID: 30326075 [No Abstract] [Full Text] [Related]
9. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study. Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487 [TBL] [Abstract][Full Text] [Related]
17. [The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis]. Wei SH; Zhao Y Zhonghua Yan Ke Za Zhi; 2017 Nov; 53(11):874-877. PubMed ID: 29141393 [TBL] [Abstract][Full Text] [Related]
18. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis and Optic Neuritis After COVID-19 Vaccination and Relapsing Optic Neuritis After COVID-19 Infection. Huang KI; Cheng CK; Peng PH J Neuroophthalmol; 2024 Jun; 44(2):e219-e221. PubMed ID: 36857140 [No Abstract] [Full Text] [Related]
19. Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibody. Yanagidaira M; Hattori T; Emoto H; Kiyosawa M; Yokota T Mult Scler Relat Disord; 2020 Feb; 38():101444. PubMed ID: 31711001 [TBL] [Abstract][Full Text] [Related]
20. Transient MOG antibody seroconversion associated with immunomodulating therapy. Pawlitzki M; Campe C; Rolfes L; Heinze HJ; Leypoldt F; Wandinger KP; Reindl M; Wildemann B; Jarius S; Körtvelyessy P Mult Scler Relat Disord; 2020 Jan; 37():101420. PubMed ID: 32172994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]